Allarity Therapeutics Inc Cash Flow-to-Debt Ratio
Allarity Therapeutics Inc cash flow-to-debt ratio. Allarity Therapeutics Inc (ALLR) has a Cash Flow-to-Debt Ratio of -0.38x as of December 2025, meaning its operating cash flow of $-3.24 Million could theoretically repay 0% of its total liabilities ($8.43 Million) in one year. Check Allarity Therapeutics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Allarity Therapeutics Inc (2015–2025)
Cash flow-to-debt ratio of Allarity Therapeutics Inc from 2015 to 2025. Historical debt coverage capacity for Allarity Therapeutics Inc across 11 annual periods. Check ALLR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Allarity Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2015–2025)
Allarity Therapeutics Inc cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Allarity Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Allarity Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.76x | $-14.82 Million | $8.43 Million | ▼ -9.8% |
| 2024 | -1.60x | $-17.35 Million | $10.84 Million | ▼ -83.6% |
| 2023 | -0.87x | $-12.74 Million | $14.61 Million | ▲ +34.4% |
| 2022 | -1.33x | $-16.82 Million | $12.65 Million | ▼ -172.4% |
| 2021 | -0.49x | $-15.05 Million | $30.85 Million | ▲ +55.9% |
| 2020 | -1.11x | $-7.25 Million | $6.55 Million | ▼ -17.1% |
| 2019 | -0.94x | $-10.11 Million | $10.70 Million | ▼ -138.2% |
| 2018 | -0.40x | $-4.24 Million | $10.69 Million | ▲ +49.9% |
| 2017 | -0.79x | $-1.34 Million | $1.70 Million | ▲ +73.4% |
| 2016 | -2.98x | $-3.98 Million | $1.34 Million | ▲ +24.0% |
| 2015 | -3.92x | $-2.03 Million | $518.15K | — |